Castle Biosciences CEO Derek Maetzold has something to be proud about. Photo courtesy of Castle Biosciences

Some Houston-area companies now have some major bragging rights — and perhaps, an influx of resumes on the way. Inc. magazine has released its new list of the country's 250 best-led midsize companies, and four Greater-Houston firms are in the spotlight.

The Houston-area companies are:

  • Castle Biosciences, Friendswood, No. 126
  • Sunova Energy, Houston, No. 156
  • Cactus Wellhead, Houston, No. 224
  • National Energy Services Reunited, Houston, No. 228

For those brushing up CVs or ready to invest, Castle Biosciences develops and commercializes diagnostic and prognostic tests for dermatologic cancers.

To compile the list, Inc. evaluated private and public U.S.-based companies with 2020 revenue of $50 million to $2 billion, or a valuation of $50 million to $10 billion. With help from Pitchbook and Shango Labs, Inc. sifted through data related to management excellence for more than 10,000 companies.

"This inaugural list of companies represents the remarkable mid-sized companies, both public and private, often founder-led, that are at the vanguard of reinventing American business," says Scott Omelianuk, editor-in-chief of Inc. magazine. "With their leadership, all businesses will benefit from an exciting, competitive future full of possibilities."

Bozeman, Montana-based software company Snowflake tops the Inc. list.

Elsewhere in Texas, An Austin company is generating buzz as the best-led midsize business in Texas. Dating app provider Bumble ranks first in Texas and 40th overall. Here's how the Austin companies fared overall:

  • Bumble, No. 40
  • BigCommerce, No. 70
  • YETI, No. 91
  • Digital Turbine, No. 101
  • Open Lending, No. 137
  • Everly Health, No. 150
  • The Zebra, No. 170
  • Helias Construction, No. 177
  • Cirrus Logic, No. 180

As for Dallas-Fort Worth, these companies landed on the list:

  • Goosehead Insurance Agency, Westlake, No. 148
  • The Container Store, Coppell, No. 153
  • Sabre, Southlake, No. 181
  • Trintech, Addison, No. 184
  • MB2 Dental, Carrollton, No. 203
------
This article originally ran on CultureMap.
Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

TMC launches new biotech partnership with Republic of Korea

international collaboration

Houston's Texas Medical Center has launched its new TMC Republic of Korea BioBridge.

The new partnership brings together the TMC with the Osong Medical Innovation Foundation, or KBIOHealth. The Biobridge aims to support the commercialization of Korean biotech and life science startups in the U.S., foster clinical research, and boost collaboration in the public, private and academic sectors.

Through the partnership, TMC will also develop a Global Innovators Launch Pad to foster U.S. market entry for international health care companies. Founders will be selected to participate in the 10-week program at the TMC Innovation Factory in Houston.

“Gene and cell therapies are driving biotech innovation, opening possibilities for treating diseases once thought untreatable," William McKeon, president and CEO of the Texas Medical Center, said in a news release. "Expanding biomanufacturing capacity is essential to delivering the next wave of these therapies, and partnerships with leading innovators will strengthen our efforts in Houston and internationally.”

McKeon officially signed the TMC Korea BioBridge Memorandum of Understanding with Myoung Su Lee, chairman of KBIOHealth, in South Korea in October.

"This collaboration marks a significant milestone for Korea’s biohealth ecosystem, creating a powerful bridge between Osong and Houston," Lee added in the release. "By combining KBIOHealth’s strength in research infrastructure and Korea’s biotech talent with TMC’s global network and accelerator platform, we aim to accelerate innovation and bring transformative solutions to patients worldwide.”

This is the seventh international strategic partnership for the TMC. It launched its first BioBridge with the Health Informatics Society of Australia in 2016. It launched its TMC Japan BioBridge, focused on advancing cancer treatments, last year. It also has BioBridge partnerships with the Netherlands, Ireland, Denmark and the United Kingdom.